FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229069980> ?p ?o ?g. }

• W4229069980 endingPage "e056264" @default.
• W4229069980 startingPage "e056264" @default.
• W4229069980 abstract "Heart failure (HF) is a growing global public health burden. However, due to the very limited regenerative capacity of mature cardiomyocytes in the adult mammalian heart, conventional treatments can only improve the symptoms of HF but fail to restore cardiac function. Heart transplantation is limited by a severe shortage of donors. Cell-based transplantation for the treatment of HF has become a promising strategy. Human-induced-pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have been tested in animal models to assess safety and efficacy. This study aims at evaluating the safety and efficacy of epicardial injection of hiPSC-CMs in patients with advanced HF during coronary artery bypass grafting (CABG) surgery.This study is a dose-escalation, placebo-controlled, single-centre phase I/IIa clinical trial. Dose escalation will be guided by a modified 3+3 design for three doses (1×108, 2×108 and 4×108 cells, sequentially). Patients with advanced heart failure will be enrolled and randomly allocated to receive epicardial injection of hiPSC-CMs during CABG surgery or CABG surgery alone, followed by a 12-month follow-up investigation. The primary endpoint is to assess the safety of hiPSC-CMs transplantation, including haemodynamic compromised sustained ventricular arrhythmias and newly formed tumours during 6 months postoperatively. The secondary endpoint is to evaluate the efficacy of epicardial injection of hiPSC-CMs and CABG surgery combination by comparison with CABG surgery alone.The study protocol has been approved by the Institutional Ethical Committee of Nanjing Drum Tower Hospital (No. SC202000102) and approved by National Health Commission of the PRC (MR-32-21-014649). Findings will be disseminated to the academic community through peer-reviewed publications and presentation at national and international meetings.NCT03763136." @default.
• W4229069980 created "2022-05-08" @default.
• W4229069980 creator A5002599726 @default.
• W4229069980 creator A5004509724 @default.
• W4229069980 creator A5016302401 @default.
• W4229069980 creator A5019342241 @default.
• W4229069980 creator A5020221391 @default.
• W4229069980 creator A5047284066 @default.
• W4229069980 creator A5050953978 @default.
• W4229069980 creator A5053170689 @default.
• W4229069980 creator A5062752842 @default.
• W4229069980 creator A5064069200 @default.
• W4229069980 creator A5077838316 @default.
• W4229069980 creator A5082443352 @default.
• W4229069980 creator A5086128666 @default.
• W4229069980 creator A5089820796 @default.
• W4229069980 date "2022-05-01" @default.
• W4229069980 modified "2023-10-18" @default.
• W4229069980 title "Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial" @default.
• W4229069980 cites W1480171680 @default.
• W4229069980 cites W1945633248 @default.
• W4229069980 cites W1970895128 @default.
• W4229069980 cites W2066390373 @default.
• W4229069980 cites W2138977668 @default.
• W4229069980 cites W2142046859 @default.
• W4229069980 cites W2166023752 @default.
• W4229069980 cites W2279233812 @default.
• W4229069980 cites W2292493149 @default.
• W4229069980 cites W2528173482 @default.
• W4229069980 cites W2757032260 @default.
• W4229069980 cites W2788579133 @default.
• W4229069980 cites W2798244438 @default.
• W4229069980 cites W2810485115 @default.
• W4229069980 cites W2891512846 @default.
• W4229069980 cites W2918653668 @default.
• W4229069980 cites W2920551789 @default.
• W4229069980 cites W2921472519 @default.
• W4229069980 cites W2945043974 @default.
• W4229069980 cites W2945250770 @default.
• W4229069980 cites W2983553575 @default.
• W4229069980 cites W2997238802 @default.
• W4229069980 cites W3006887679 @default.
• W4229069980 cites W3012728641 @default.
• W4229069980 cites W3017823242 @default.
• W4229069980 cites W3024584791 @default.
• W4229069980 cites W3045137842 @default.
• W4229069980 doi "https://doi.org/10.1136/bmjopen-2021-056264" @default.
• W4229069980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35523485" @default.
• W4229069980 hasPublicationYear "2022" @default.
• W4229069980 type Work @default.
• W4229069980 citedByCount "10" @default.
• W4229069980 countsByYear W42290699802022 @default.
• W4229069980 countsByYear W42290699802023 @default.
• W4229069980 crossrefType "journal-article" @default.
• W4229069980 hasAuthorship W4229069980A5002599726 @default.
• W4229069980 hasAuthorship W4229069980A5004509724 @default.
• W4229069980 hasAuthorship W4229069980A5016302401 @default.
• W4229069980 hasAuthorship W4229069980A5019342241 @default.
• W4229069980 hasAuthorship W4229069980A5020221391 @default.
• W4229069980 hasAuthorship W4229069980A5047284066 @default.
• W4229069980 hasAuthorship W4229069980A5050953978 @default.
• W4229069980 hasAuthorship W4229069980A5053170689 @default.
• W4229069980 hasAuthorship W4229069980A5062752842 @default.
• W4229069980 hasAuthorship W4229069980A5064069200 @default.
• W4229069980 hasAuthorship W4229069980A5077838316 @default.
• W4229069980 hasAuthorship W4229069980A5082443352 @default.
• W4229069980 hasAuthorship W4229069980A5086128666 @default.
• W4229069980 hasAuthorship W4229069980A5089820796 @default.
• W4229069980 hasBestOaLocation W42290699801 @default.
• W4229069980 hasConcept C126322002 @default.
• W4229069980 hasConcept C141071460 @default.
• W4229069980 hasConcept C142724271 @default.
• W4229069980 hasConcept C164705383 @default.
• W4229069980 hasConcept C203092338 @default.
• W4229069980 hasConcept C204787440 @default.
• W4229069980 hasConcept C27081682 @default.
• W4229069980 hasConcept C2778198053 @default.
• W4229069980 hasConcept C2778789114 @default.
• W4229069980 hasConcept C2778849806 @default.
• W4229069980 hasConcept C2911091166 @default.
• W4229069980 hasConcept C535046627 @default.
• W4229069980 hasConcept C71924100 @default.
• W4229069980 hasConceptScore W4229069980C126322002 @default.
• W4229069980 hasConceptScore W4229069980C141071460 @default.
• W4229069980 hasConceptScore W4229069980C142724271 @default.
• W4229069980 hasConceptScore W4229069980C164705383 @default.
• W4229069980 hasConceptScore W4229069980C203092338 @default.
• W4229069980 hasConceptScore W4229069980C204787440 @default.
• W4229069980 hasConceptScore W4229069980C27081682 @default.
• W4229069980 hasConceptScore W4229069980C2778198053 @default.
• W4229069980 hasConceptScore W4229069980C2778789114 @default.
• W4229069980 hasConceptScore W4229069980C2778849806 @default.
• W4229069980 hasConceptScore W4229069980C2911091166 @default.
• W4229069980 hasConceptScore W4229069980C535046627 @default.
• W4229069980 hasConceptScore W4229069980C71924100 @default.
• W4229069980 hasIssue "5" @default.
• W4229069980 hasLocation W42290699801 @default.
• W4229069980 hasLocation W42290699802 @default.

• next